As our expert consensus recommendations aim to advance clinical practice and patient care in ophthalmology, we are passionate about the widespread dissemination of our practical information and educational tools. We seek to engage clinicians by delivering presentations, debates, and symposia at meetings and congresses worldwide, and enabling interactions between our members and the wider ophthalmic community.
Vision Academy members Antonia Joussen, Daniel Pauleikhoff, and Anat Loewenstein presented at the DOG (Deutsche Ophthalmologische Gesellschaft; German Ophthalmological Society) virtual congress in October 2021. View the presentations on the characterization of AMD subtypes and the futility of anti-VEGF treatment, as well as the consecutive panel discussion.
COPHy EU 2020
The 2020 COPHy EU meeting was held virtually due to the COVID-19 pandemic. The Vision Academy session included debates on retinal pigment epithelial tear and treat-and-extend retreatment/extension decisions. Professor Anat Loewenstein also presented a special session on “Current approaches to intravitreal injections in an era of COVID-19”.
Vision Academy Annual Meeting 2020
Dr. William W. Li is the President, Medical Director, and co-founder of the Angiogenesis Foundation in the United States, whose recent work includes research into vascular effects and angiogenesis in COVID-19. Watch Dr. Li’s presentation from the 2020 Vision Academy Annual Meeting for highlights from his research findings on angiogenesis and COVID-19.
Scandinavian Regional Webinar
Steering Committee members Anat Loewenstein, Monica Lövestam-Adrian, and David Wong took part in a webinar in November 2020 to debate two key topics: managing occurrences of retinal pigment epithelial tear and recommendations on suspending treatment in cases of futility.
The 3rd biannual Florence Retina Meeting (FLORetina) took place on June 6–9, 2019 in Florence, Italy. The Vision Academy session included debates on Academy recommendations on the management of subfoveal hemorrhage, suspending anti-VEGF treatment in cases of futility, and the optimal treatment regimen with anti-VEGF.
COPHy EU 2019
The 10th Annual Congress on Controversies in Ophthalmology: Europe (COPHy EU) took place on April 4–6, 2019 in Dublin, Ireland. The Vision Academy session included debates on Academy recommendations on monitoring of the fellow eye and treating diabetic retinopathy.
Vision Academy Annual Meeting 2019
Vision Academy Annual Meeting 2019 The Vision Academy Annual Meeting took place on March 15–16, 2019 in Amsterdam, the Netherlands. The meeting included updates on clinical challenges for the Academy in 2019, presentations on the clinical implications of the latest ophthalmic data, and discussion on patient engagement and how effective uptake and implementation of treatment guidelines can be achieved.
COPHy AA 2019
The 5th Annual Congress on Controversies in Ophthalmology: Asia-Australia (COPHy AA) took place on February 22–23, 2019 in Shanghai, China. The Vision Academy session included debates on Academy recommendations on monitoring of the fellow eye and suspending anti-VEGF therapy in cases of futility.
COPHy EU 2018
The 9th Annual COPHy EU Congress took place on March 22–24, 2018 in Athens, Greece. The Vision Academy session included debates on the optimal treatment regimen with anti-VEGF and suspending anti VEGF treatment in cases of futility.
COPHy AA 2018
The 4th Annual COPHy AA Congress took place on February 1–4, 2018 in Manila, the Philippines. The Vision Academy session included debates on two published Viewpoints: ‘Fundamental principles of an anti-VEGF treatment regimen’ and ‘Use of topical antibiotics with intravitreal injections’.
The 53rd EASD Annual Meeting was held in Lisbon, Portugal on September 11–15, 2017. The Vision Academy presented data on two topics at the meeting: ‘The association between DR and other complications of diabetes’ and ‘Diabetic eye disease – A treatable complication of diabetes’.
The 8th World Congress on Controversies in Ophthalmology (COPHy) took place on March 30–April 1, 2017 in Madrid, Spain. The Vision Academy session included debates on two published Viewpoints: ‘Bilateral anti-VEGF treatment’ and ‘Use of topical antibiotics with intravitreal injections’.